Mamo Biniyam Tedla, Bonger Zelalem Tazu, Senbato Feyissa Regassa, Eguale Tadesse, Akililu Kibrewossen Kiflu, Welelaw Samuel Muluye, Zeleke Eden Dagnachew, Demtse Asrat, Assefa Turegne, Yirgu Ruth Woldeyohannes, Mekuria Zelalem, Balada-Llasat Joan-Miquel, Wang Shu-Hua
Ohio State Global One Health, LLC, Addis Ababa, Ethiopia.
Department of Pediatrics and Child Health, School of Medicine, College of health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
PLoS One. 2025 May 13;20(5):e0323288. doi: 10.1371/journal.pone.0323288. eCollection 2025.
Neonatal sepsis is a leading cause of mortality and morbidity. To improve the clinical outcomes of neonates with sepsis, treatment should be based on bacteriological identification and antibiotic susceptibility. This study aims to assess the proportion of culture-positive gram-negative bacteria (GNB), the antibiotic susceptibility patterns, and treatment outcomes of neonatal sepsis at two neonatal intensive care units (NICUs) in Addis Ababa.
A retrospective observational study was conducted among gram-negative sepsis suspected neonates admitted at Zewditu Memorial Hospital and Tikur Anbessa Specialized Hospital NICUs from January to December 2023. All neonates who were suspected of having sepsis were included in this study. Standard microbiological culture and biochemical tests were used to identify bacterial species and the Kirby-Bauer disc diffusion assay using Mueller-Hinton agar was employed to test the antimicrobial susceptibility of bacterial isolates as per Clinical Laboratory Standard Institute guidelines. Descriptive statistics were used to describe the study variables. Bivariable and multivariable logistic regression analyses were used to identify the factors associated with the treatment outcomes of neonatal sepsis. A p-value < 0.05 was set for statistical significance.
A total of 933 neonates were diagnosed with sepsis during the study period, of which 166 neonates were enrolled in the study for gram-negative sepsis: 84 (51%) were female and 97 (58%) had early onset sepsis. The median length of hospital stay was nine days with interquartile range of 16 days. The predominant GNB identified was Klebsiella spp. (n = 89; 49%), followed by Acinetobacter spp. (n = 38; 21%) and Escherichia coli (n = 19; 11%). In both hospitals, Klebsiella spp. was resistant to most of the routinely prescribed antibiotics: (n = 68; 89%) were resistant to ceftriaxone, (n = 56, 89%) cefepime and (n = 60; 75%) to gentamicin. Lower rates of resistance were recorded for other antibiotics such as ciprofloxacin (n = 12; 18%), ertapenem (n = 11; 16%), meropenem (n = 9; 13%), and amikacin (n = 3; 4%). A total of 92 (55%) neonates with the GNB isolated in the current study had multidrug-resistant (MDR) organisms. The study found that newborns with MDR infections were five times more likely to experience poor treatment outcomes compared to those with non-resistant strains (AOR, 5.23 95% CI [2.59, 11.11]). In addition, newborns who stayed less than seven days, compared to those who spent seven or more days in the hospital was four times (AOR: 4.16, 95% CI (2.0-9.01) more likely to experience poor health outcomes.
Klebsiella spp. was the most common GNB isolated from the NICUs. More than half neonatal sepsis was caused by MDR organisms and associated with significant poor treatment outcomes. high prevalence of MDR-gram-negative bacteremia is alarming and highlights the need for the implementation of routine surveillance and infection control measures to decrease morbidity and mortality and to combat the development of antimicrobial resistance.
新生儿败血症是导致死亡和发病的主要原因。为改善败血症新生儿的临床结局,治疗应基于细菌学鉴定和抗生素敏感性。本研究旨在评估亚的斯亚贝巴两家新生儿重症监护病房(NICUs)中培养阳性革兰氏阴性菌(GNB)的比例、抗生素敏感性模式以及新生儿败血症的治疗结局。
对2023年1月至12月在泽韦迪图纪念医院和提库尔·安贝萨专科医院新生儿重症监护病房收治的疑似革兰氏阴性败血症新生儿进行回顾性观察研究。所有疑似患有败血症的新生儿均纳入本研究。采用标准微生物培养和生化试验鉴定细菌种类,并按照临床实验室标准协会指南,使用穆勒-欣顿琼脂通过 Kirby-Bauer 纸片扩散法检测细菌分离株的抗菌敏感性。使用描述性统计来描述研究变量。采用双变量和多变量逻辑回归分析来确定与新生儿败血症治疗结局相关的因素。设定p值<0.05为具有统计学意义。
在研究期间,共有933例新生儿被诊断为败血症,其中166例新生儿因革兰氏阴性败血症纳入本研究:84例(51%)为女性,97例(58%)为早发型败血症。住院时间中位数为9天,四分位间距为16天。鉴定出的主要革兰氏阴性菌是克雷伯菌属(n = 89;49%),其次是不动杆菌属(n = 38;21%)和大肠杆菌(n = 19;11%)。在两家医院中,克雷伯菌属对大多数常规使用的抗生素耐药:(n = 68;89%)对头孢曲松耐药,(n = 56,89%)对头孢吡肟耐药,(n = 60;75%)对庆大霉素耐药。其他抗生素如环丙沙星(n = 12;18%)、厄他培南(n = 11;16%)、美罗培南(n = 9;13%)和阿米卡星(n = 3;4%)的耐药率较低。本研究中分离出革兰氏阴性菌的92例(55%)新生儿具有多重耐药(MDR)菌。研究发现,与非耐药菌株相比,患有多重耐药感染的新生儿治疗结局不良的可能性高五倍(调整后比值比,5.23 95%置信区间[2.59, 11.11])。此外,住院时间少于7天的新生儿与住院7天或更长时间的新生儿相比,健康结局不良的可能性高四倍(调整后比值比:4.16,95%置信区间(2.0 - 9.01))。
克雷伯菌属是新生儿重症监护病房分离出的最常见革兰氏阴性菌。超过一半的新生儿败血症由多重耐药菌引起,并与显著不良的治疗结局相关。多重耐药革兰氏阴性菌血症的高患病率令人担忧,突出了实施常规监测和感染控制措施以降低发病率和死亡率以及对抗抗菌药物耐药性发展的必要性。